Q3 2010

Filed Nov 15, 2010 · 10-Q · 46 days after period end · 0001144204-10-060835

Q3 2010 · 10-Q

Revenue

$9.18M

no prior Q3 2009 on file

Net Income

-$3.64M

no prior Q3 2009 on file

EPS Diluted

-$0.70

no prior Q3 2009 on file

Operating Income-$3,668,000—

Operating Cash Flow

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2010 · filed Nov 15, 2010 · 46 d after period end

Protagenic Therapeutics, Inc.\new · CIK 1022899 · Engraved from SEC EDGAR